Founder, Chairman, and CEO of Prelude, Martin Varsavsky is a Spanish entrepreneur who has founded seven companies in the USA and Europe in the past 25 years, all of which are based on new technologies that he identified in their infancy and helped grow. Forbes recently wrote a feature about Varsavsky: http://www.forbes.com/sites/miguelhelft/2016/10/17/prelude-fertility-200-million-startup-stop-biological-clock/#6e46ad947d04.
Varsavsky has applied this same approach in creating Prelude, a comprehensive fertility company with a focus on providing progressive fertility care to preserve people`s ability to have healthy babies when they`re ready. The company was established to educate and inform men and women about their fertility in their early 20s, follow them through their 30's and 40's, and to offer the latest advances in reproductive science and technology through The Prelude Method. The Prelude Method is a four-step process that includes egg and sperm freezing, genetic testing, embryo creation, and single embryo transfer. By coupling earlier decision-making with the latest reproductive science and technology, The Prelude Method can dramatically increase the probability of having a healthy baby and decrease the chances of requiring infertility therapy later in life.
• The World Health Organization ranks infertility as the third most serious disease worldwide after cancer and cardiovascular disease
• According to the American Society for Reproductive Medicine, a woman`s fertility begins to drop in her late 20`s and early 30`s. The organization advises that those who delay pregnancy until after age 35 should seek testing and treatment, while 'remaining realistic about the chances for success with infertility therapy.'
• 1 in 8 couples, or 12% of women, are infertile, as they have trouble getting pregnant or sustaining a pregnancy
• There is a 13x increased chance of Attention Deficit Disorder among other health issues when men over 40 father children
• Those who do conceive at a later age face significant health risks: 80% of embryos from women over 40 years old carry chromosomal abnormalities, and five percent of newborns are affected by congenital disease.
For more information go to http://preludefertility.com/